SEC Form 4 · accession 0001582945-15-000003
CEREBAIN BIOTECH CORP. · CBBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wesley D. Tate
Officer — Chief Financial Officer · Director
Period of report
Oct 1, 2014
Accepted (ET)
Sep 21, 2015 · 1:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453099
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 11, 2015 | A | 250,000 | $0.31 | A | 322,203 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock OptionsF2,F3 | $1.20 | Oct 1, 2014 | A | 50,000 | A | Oct 1, 2014 | Oct 1, 2024 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The Reporting Person was issued the shares from the Issuer in lieu of $77,500 due to the Reporting Person by the Issuer.
- F2The options vest at 10,000 per year beginning on October 1, 2014.
- F3The options expire ten years after they vest.